LabCorp is Scheduled to Present at the Goldman Sachs 36th Annual Global Healthcare Conference
June 02 2015 - 7:45AM
Business Wire
Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:
LH) today announced it will participate at the Goldman Sachs 36th
Annual Global Healthcare Conference. LabCorp’s presentation is
planned for Tuesday, June 9, 2015 at 5:00 PM (ET).
A live audio webcast will be available via the Company website
at www.labcorp.com and archived for replay.
About LabCorp®
Laboratory Corporation of America® Holdings, an S&P 500
company, is the world’s leading healthcare diagnostics company,
providing comprehensive clinical laboratory services through
LabCorp Diagnostics, and end-to-end drug development support
through Covance Drug Development. LabCorp is a pioneer in
commercializing new diagnostic technologies and is improving
people’s health by delivering the combination of world-class
diagnostics, drug development and knowledge services. With combined
revenue proforma for the Covance acquisition in excess of $8.5
billion in 2014 and more than 48,000 employees in over 60
countries, LabCorp offers innovative solutions to healthcare
stakeholders. LabCorp clients include physicians, patients and
consumers, biopharmaceutical companies, government agencies,
managed care organizations, hospitals, and clinical labs. To learn
more about Covance Drug Development, visit www.covance.com. To
learn more about LabCorp and LabCorp Diagnostics, visit
www.labcorp.com.
This press release contains forward-looking statements including
with respect to estimated 2015 guidance and the impact of various
factors on operating results. Each of the forward-looking
statements is subject to change based on various important factors,
including without limitation, competitive actions in the
marketplace, adverse actions of governmental and other third-party
payers and the results from the Company’s acquisition of Covance.
Actual results could differ materially from those suggested by
these forward-looking statements. Further information on potential
factors that could affect LabCorp’s operating and financial results
is included in the Company’s Form 10-K for the year ended December
31, 2014, including in each case under the heading risk factors,
and in the Company’s other filings with the SEC, as well as in the
risk factors included in Covance’s filings with the SEC. The
information in this press release should be read in conjunction
with a review of the Company’s filings with the SEC including the
information in the section of the Company’s Form 10-K for the year
ended December 31, 2014, subsequent Forms 10-Q, under the heading
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150602006082/en/
LabCorpPaul Surdez, 336-436-5076www.labcorp.com
Laboratory Corporation o... (NYSE:LH)
Historical Stock Chart
From Apr 2024 to May 2024
Laboratory Corporation o... (NYSE:LH)
Historical Stock Chart
From May 2023 to May 2024